Skip to main content

Site notifications

CINQAIR reslizumab 100 mg/10 mL concentrated solution for intravenous infusion vial Cancelled under Section 30(1)(c) of the Act

Product name
CINQAIR reslizumab 100 mg/10 mL concentrated solution for intravenous infusion vial
ARTG details
  • 277278
Date of effect
Decision type
Cancelled under Section 30(1)(c) of the Act